NEW YORK (Reuters) – OxyContin maker Purdue Pharma LP is nearing a partial settlement to resolve widespread litigation over its alleged position in fueling the U.S. opioid disaster and plans to tussle with states opposing its settlement supply in chapter proceedings beginning as quickly as subsequent week, individuals conversant in the matter stated.

FILE PHOTO: Bottles of prescription painkiller OxyContin drugs, made by Purdue Pharma LP sit on a counter at an area pharmacy in Provo, Utah, U.S., April 25, 2017. REUTERS/George Frey/File Photograph

Late on Tuesday, lead legal professionals representing greater than 2,000 cities, counties and different plaintiffs suing Purdue, alongside…

Source link